February 14, 2023
Beverly Lorell comments on issues of data integrity and why it represents high stakes for both sponsors and clinical investigators
October 31, 2022
Mark Brown, Pete Leininger and Beverly Lorell explain how the COVID-19 pandemic has upended the conduct of clinical trials in a number of ways
December 7, 2021
King & Spalding Advises Oaktree Acquisition Corp. II in its Merger with Alvotech
November 30, 2022
Are You Prepared? FDA’s Proposed Rules to Modify Protection of Human Subjects and IRB Oversight
November 1, 2022
Pharmaceutical University 2022
September 9, 2021
14th Annual King & Spalding Medical Device Summit
March 7, 2023
FDA Issues Draft Guidance on “External Controls” in Clinical Trials to Support Safety and Efficacy of a Drug
November 14, 2022
FDA (Finally!) Issues Proposed Rule to Amend FDA Regulations on the Protection of Human Subjects and Institutional Review Boards
November 1, 2022
Clinical Data Integrity: FDA and DOJ Enforcement Priorities
February 8, 2022
Europe - Between The EU Clinical Trials Regulation And The UK Guideline On Clinical Trials